KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Cash (2016 - 2025)

Historic Change in Cash for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to -$35.0 million.

  • Evolent Health's Change in Cash fell 24626.66% to -$35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 11567.87%. This contributed to the annual value of -$45.0 million for FY2024, which is 64176.41% down from last year.
  • Latest data reveals that Evolent Health reported Change in Cash of -$35.0 million as of Q3 2025, which was down 24626.66% from -$99.9 million recorded in Q2 2025.
  • Evolent Health's Change in Cash's 5-year high stood at $99.3 million during Q1 2025, with a 5-year trough of -$99.9 million in Q2 2025.
  • For the 5-year period, Evolent Health's Change in Cash averaged around -$11.5 million, with its median value being -$1.0 million (2023).
  • As far as peak fluctuations go, Evolent Health's Change in Cash crashed by 466156.27% in 2021, and later soared by 496503.36% in 2024.
  • Quarter analysis of 5 years shows Evolent Health's Change in Cash stood at $73.2 million in 2021, then tumbled by 72.21% to $20.3 million in 2022, then tumbled by 105.12% to -$1.0 million in 2023, then skyrocketed by 4965.03% to $50.6 million in 2024, then plummeted by 169.04% to -$35.0 million in 2025.
  • Its Change in Cash was -$35.0 million in Q3 2025, compared to -$99.9 million in Q2 2025 and $99.3 million in Q1 2025.